DNA Damage Repair Deficiency in Prostate Cancer.

Trends in Cancer
Susanne Burdak-RothkammKai Rothkamm

Abstract

Molecular-targeted therapies and treatment stratification based on molecular biomarkers have rapidly gained momentum in the therapeutic spectrum for patients with prostate cancer, particularly those with aggressive disease. DNA damage repair (DDR) pathways are commonly impaired in prostate cancer. Recent studies have detailed mechanisms interconnecting the DDR with the androgen receptor (AR) signaling pathway as well as its interplay with the immune response. The prominent role of DDR deficiency in prostate cancer development and treatment response encourages innovative strategies for the detection of DDR deficiency in individual tumors. In this review, we describe recent preclinical and early clinical data on the exploitation of DDR defects as predictive biomarkers and also as molecular therapeutic targets.

References

Apr 2, 2003·Urological Research·Antonio M SerafinLothar Böhm
Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
Oct 16, 2010·Cancer Research·Nuria Coll BastusYong-Jie Lu
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
May 23, 2012·Nature Genetics·Christopher E BarbieriLevi A Garraway
Mar 16, 2013·Cancer Research·Lia BurkhardtRonald Simon
Sep 13, 2013·Cancer Discovery·Jonathan F GoodwinKaren E Knudsen
Nov 10, 2013·Cancer Discovery·Jiri BartekJirina Bartkova
Mar 25, 2014·Current Opinion in Genetics & Development·Ludmil B Alexandrov, Michael R Stratton
Sep 6, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Charlotte F KweldamGeert Jlh van Leenders
Sep 30, 2014·Annals of Diagnostic Pathology·Kenneth A IczkowskiDavid G Bostwick
Mar 15, 2015·Cancer Research·Lindsey Ulkus RodriguesScott D Cramer
Mar 17, 2015·Environmental and Molecular Mutagenesis·Kai RothkammSusanne Burdak-Rothkamm
May 23, 2015·Cell·Dan RobinsonArul M Chinnaiyan
Jul 15, 2015·European Urology·Jonathan I EpsteinEric A Klein
Oct 29, 2015·The New England Journal of Medicine·Joaquin MateoJohann S de Bono
Nov 6, 2015·Science Translational Medicine·Firas L TarishThomas Helleday
Nov 7, 2015·Cell·UNKNOWN Cancer Genome Atlas Research Network
Jan 12, 2016·Nature Structural & Molecular Biology·Eric MetzgerRoland Schüle
May 14, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Niall M CorcoranChristopher M Hovens
Jul 29, 2016·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Tomokazu HasegawaKoh-Ichi Sakata
Apr 7, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T R ShenoyH Wu
Apr 30, 2017·Cancer Discovery·Jane GoodallUNKNOWN TOPARP-A investigators
Jul 1, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marijo BilusicJames L Gulley

❮ Previous
Next ❯

Citations

Jan 16, 2021·The Urologic Clinics of North America·Sujit S NairAshutosh K Tewari
Jul 18, 2021·Current Oncology Reports·Bryden ConsidineMichael E Hurwitz

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.